Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fabiola Atzeni, Antonio Carriero, Laura Boccassini & Salvatore D’Angelo. (2021) Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis. ImmunoTargets and Therapy 10, pages 141-153.
Read now
Read now
Francesca Marino, Salvatore D’Angelo, Ignazio Francesco Masala, Elisabetta Gerratana, Valeria Nucera, Laura La Corte, Manuela Giallanza, Piercarlo Sarzi-Puttini & Fabiola Atzeni. (2020) Toxicological considerations in the treatment of axial spondylo-arthritis. Expert Opinion on Drug Metabolism & Toxicology 16:8, pages 663-672.
Read now
Read now
Hiroshi Ueno, Atsumi Shimada, Shunsuke Suemitsu, Shinji Murakami, Naoya Kitamura, Kenta Wani, Yu Takahashi, Yosuke Matsumoto, Motoi Okamoto & Takeshi Ishihara. (2020) Increased anxiety-related behavior in mice following β-citronellol inhalation. Libyan Journal of Medicine 15:1.
Read now
Read now
Articles from other publishers (12)
Chen Dong, Jürgen Braun & Kevin Sheng‐Kai Ma. (2023) Safety and efficacy of pharmacological treatments for axial spondyloarthritis. International Journal of Rheumatic Diseases 26:11, pages 2130-2133.
Crossref
Crossref
Xinping Tian, Mengtao Li, Shengyun Liu, Xiaomei Leng, Qian Wang, Jiuliang Zhao, Yi Liu, Yan Zhao, Yizhi Zhang, Huji Xu, Jieruo Gu & Xiaofeng Zeng. (2023) Consensus on targeted drug therapy for spondyloarthritis. Rheumatology and Immunology Research 4:2, pages 47-59.
Crossref
Crossref
Jūlija Zepa, Vladimirs Lavrentjevs, Santa Miķēna, Jānis Arājs, Tamāra Zavgorodnaja, Evita Sikora, Sarmīte Ābelīte, Renāte Diura, Ineta Balčune, Kristīne Ivanova, Pauls Rubīns, Ilva Trapiņa, Daina Andersone & Inita Buliņa. (2023) Outpatient Care Aspects of Rheumatic Patients in Latvia: Real Life Data in the Context of the First Month of the COVID-19 Pandemic. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 77:1, pages 24-32.
Crossref
Crossref
M. Elaine Husni, Atul Deodhar, Sergio Schwartzman, Soumya D. Chakravarty, Elizabeth C. Hsia, Jocelyn H. Leu, Yiying Zhou, Kim H. Lo & Arthur Kavanaugh. (2022) Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Arthritis Research & Therapy 24:1.
Crossref
Crossref
Johannes Nossent, Charles Inderjeeth, Helen Keen, David Preen, Ian Li & Erin Kelty. (2021) The Association Between TNF Inhibitor Therapy Availability and Hospital Admission Rates for Patients with Ankylosing Spondylitis. A Longitudinal Population-Based Study. Rheumatology and Therapy 9:1, pages 127-137.
Crossref
Crossref
Antonio Carriero, Ennio Lubrano, Valentina Picerno, Angela Anna Padula & Salvatore D’Angelo. (2021) Corticosteroid injection treatment for dactylitis in psoriatic arthritis. Therapeutic Advances in Musculoskeletal Disease 13, pages 1759720X2110418.
Crossref
Crossref
Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, Joachim Sieper, Xenofon Baraliakos, Filip Van den Bosch, Walter P Maksymowych, Joerg Ermann, Jessica A Walsh, Tetsuya Tomita, Atul Deodhar, Désirée van der Heijde, Xiaoqi Li, Fangyi Zhao, Clinton C Bertram, Gaia Gallo, Hilde Carlier & Lianne S Gensler. (2020) Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W). Annals of the Rheumatic Diseases 79:2, pages 176-185.
Crossref
Crossref
Sonam Kiwalkar, Secia Beier & Atul Deodhar. (2019) Ixekizumab for treating ankylosing spondylitis. Immunotherapy 11:15, pages 1273-1282.
Crossref
Crossref
Kathleen M. Andersen, Ayano Kelly, Anne Lyddiatt, Clifton O. BinghamIIIIII, Vivian P. Bykerk, Adena Batterman, Joan Westreich, Michelle K. Jones, Marita Cross, Peter M. Brooks, Lyn March, Beverley Shea, Peter Tugwell, Lee S. Simon, Robin Christensen & Susan J. Bartlett. (2019) Patient Perspectives on DMARD Safety Concerns in Rheumatology Trials: Results from Inflammatory Arthritis Patient Focus Groups and OMERACT Attendees Discussion. The Journal of Rheumatology 46:9, pages 1168-1172.
Crossref
Crossref
Erwin Dreesen & Ann Gils. (2019) Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases. Therapeutic Drug Monitoring 41:2, pages 131-141.
Crossref
Crossref
Atul Deodhar, Denis Poddubnyy, Cesar Pacheco‐Tena, Carlo Salvarani, Eric Lespessailles, Proton Rahman, Pentti Järvinen, Juan Sanchez‐Burson, Karl Gaffney, Eun Bong Lee, Eswar Krishnan, Silvia Santisteban, Xiaoqi Li, Fangyi Zhao, Hilde Carlier, John D. Reveille, Christopher Antolini, Valderilio Azevedo, Magnus Barkham, Aaron Alejandro Barrera Rodriguez, Alberto Berman, Tomasz Blicharski, Jan Brzezicki, Gerd Burmester, Judith Carrio, Eduardo Collantes, Bernard Combe, Fidencio Cons‐Molina, Gregorio Cortes‐Maisonet, Anna Dudek, Sergio Duran Barragan, Ori Elkayam, Kathleen Flint, Mauro Galeazzi, Norman Gaylis, David Goddard, Carlos Gonzalez Fernandez, Philippe Goupille, Jordi Gratacos Masmitja, Maria Greenwald, Elisa Gremese, Seung Jae Hong, Mary Howell, Pawel Hrycaj, Akgun Ince, Ji Hyeon Ju, Jeffrey Kaine, Seong Wook Kang, Mauro Keiserman, Tae‐Hwan Kim, Alan Kivitz, Steven Klein, Joel Kremer, Sang Heon Lee, Chang Keun Lee, Sang‐Hoon Lee, Roger Lidman, James Loveless, Eleonora Lucero, Jose Maldonado Cocco, Flora Marcolino, Xavier Mariette, Daksha Mehta, Frederic Morin, Yolanda Moscovici, Eric Mueller, Eduardo Mysler, Francisco Navarro Blasco, Minh Nguyen, Carlos Pantojas, Min‐Chan Park, Amarilis Perez‐De Jesus, Eric Peters, Rafal Plebanski, Roel Querubin, Cesar Ramos Remus, Tatiana Reitblat, Tania Rivera, Juan Cruz Rizo Rodriguez, Michael Sayers, Antonio Scotton, Craig Scoville, David Shaw, Kichul Shin, Atul Singhal, Cassandra Skinner, Oscar Soto‐Raices, Martin Soubrier, Malgorzata Szymanska, Christine Thai, Marleen Sande, Alvin Wells, Rafal Wojciechowski, Ricardo Xavier, Antonio Ximenes & Devy Zisman. (2019)
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results From a Phase
III
Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
. Arthritis & Rheumatology 71:4, pages 599-611.
Crossref
Crossref
Priscila L. Santos, João Pedro S.C.F. Matos, Laurent Picot, Jackson R.G.S. Almeida, Jullyana S.S. Quintans & Lucindo J. Quintans-Júnior. (2019) Citronellol, a monoterpene alcohol with promising pharmacological activities - A systematic review. Food and Chemical Toxicology 123, pages 459-469.
Crossref
Crossref